MANNKIND CORP
For the period ended Dec 31, 2024. Filed Feb 26, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 26, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| MANNKIND CORPORATION | |
| By: | /s/ Michael E. Castagna |
| Michael E. Castagna | |
| Chief Executive Officer |
Dated: February 26, 2025
POWER OF ATTORNEY
KNOW ALL BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Michael E. Castagna and David Thomson, and each of them, as his true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him and in his name, place, and stead, in any and all capacities, to sign any and all amendments to this report, and any other documents in connection therewith, and to file the same, with all exhibits thereto, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them or their or his substitute or substituted, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Michael E. CastagnaMichael E. Castagna | Chief Executive Officer and Director(Principal Executive Officer) | February 26, 2025 |
| /s/ Christopher B. PrentissChristopher B. Prentiss | Chief Financial Officer(Principal Financial and Accounting Officer) | February 26, 2025 |
| /s/ James S. ShannonJames S. Shannon, M.D., MRCP (UK) | Chairman of the Board of Directors | February 26, 2025 |
| /s/ Steven B. BinderSteven B. Binder | Director | February 26, 2025 |
| /s/ Ronald J. ConsiglioRonald J. Consiglio | Director | February 26, 2025 |
| /s/ Michael Friedman, M.D.Michael Friedman, M.D. | Director | February 26, 2025 |
| /s/ Jennifer GrancioJennifer Grancio | Director | February 26, 2025 |
| /s/ Anthony C. Hooper | Director | February 26, 2025 |
| Anthony C. Hooper | ||
| /s/ Sabrina Kay, PhDSabrina Kay, PhD | Director | February 26, 2025 |
| /s/ Christine Mundkur | Director | February 26, 2025 |
| Christine Mundkur | ||
INDEX TO FINANCIAL STATEMENTS
| Report of Independent Registered Public Accounting Firm | 68 |
|---|---|
| Consolidated Statements of Operations | 70 |
| Consolidated Statements of Comprehensive Income (Loss) | 71 |
| Consolidated Balance Sheets | 72 |
| Consolidated Statements of Stockholders’ Deficit | 73 |
| Consolidated Statements of Cash Flows | 74 |
| Notes to Consolidated Financial Statements | 76 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.